<DOC>
	<DOCNO>NCT01928953</DOCNO>
	<brief_summary>This prospective hybrid longitudinal study conduct United States ( US ) , Canada , United Kingdom ( UK ) , Germany . To obtain complete comprehensive understand burden opioid-induced constipation ( OIC ) country , study use combination web-based , longitudinal patient survey , retrospective data abstraction medical record , prospective physician survey . The primary objective study estimate rate inadequate response laxative ( LIR ) , define sufficient laxative use ( least one laxative use ≥ four time per reference period ) , inadequate response ( define few three bowel movement ( BMs ) OR least one follow symptom Patient Assessment Constipation Symptoms ( PAC-SYM ) measure score moderate , severe severe : BMs hard , strain BM , feel like n't `` finish '' BM , feel like pas BM could ) , cohort non-cancer pain cancer pain ( separately ) participant OIC , country overall . The secondary study objective follow : 1 . To estimate rate LIR two subgroup : 1xLIR 2xLIR . 1xLIR defined use least one laxative agent ≥ 4 time reference period 2xLIR define use least two laxative agent , use ≥ 4 time reference period ; 2 . To describe baseline demographic clinical characteristic , include prior health status , comorbidities , constipation-related GI symptom , concomitant medication patient OIC ; 3 . To describe drug utilization self-management OIC ; 4 . To describe pre-index post-index healthcare resource utilization estimate cost associated diagnosis , treatment , general management OIC ( include laxative use ) event attribute OIC , include direct indirect cost ; 5 . To describe patient-reported impact OIC health-related quality life , productivity , pain management ; 6 . To describe patient-reported treatment satisfaction laxative use ; 7 . To describe physician-reported awareness OIC symptom understand patient-reported impact OIC .</brief_summary>
	<brief_title>Longitudinal Study Patients With Opioid-Induced Constipation</brief_title>
	<detailed_description />
	<mesh_term>Constipation</mesh_term>
	<mesh_term>Analgesics , Opioid</mesh_term>
	<criteria>Patient receive minimum total daily dose 30 mg oral morphine , equianalgesic amount [ ] 1 opioid therapy , minimum 4 week chronic pain cancer relate pain Presence OIC past 2 week ( cancer patient ) Patient current diagnosis cancer currently remission cancerrelated pain Internet access able willing complete longitudinal webbased survey Patient able understand comply requirement study , judge investigator ( include ability read write use Patient unable refuse provide informed consent ; Patient access computer internet connectivity , unable use computer complete webbased survey ; Based clinical judgment , patient history chronic constipation ( i.e . clinical diagnosis , note medical record , patient history ) ; Patient history ( current ) colon cancer ( primary metastatic ) ( i.e. , clinical diagnosis Patient receive investigational medication treat constipation participate study involve investigational compound naloxegol within ≤90 day prior baseline visit</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>opioid induced constipation patient without cancer cancer</keyword>
</DOC>